Management of retinal vein occlusion - Consensus document

Ophthalmologica

Volumn 226, Issue 1, 2011, Pages 4-28

  Coscas, Gabriel ^a   Loewenstein, Anat ^b   Augustin, Albert ^c   Bandello, Francesco ^d   Battaglia Parodi, Maurizio ^d   Lanzetta, Paolo ^e   Monés, Jordi ^f   De Smet, Marc ^g   Soubrane, Gisèle ^a   Staurenghi, Giovanni ^h  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^b TEL AVIV UNIVERSITY   (Israel)

^c STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e UNIVERSITY OF UDINE   (Italy)

^f CENTRO MÉDICO TEKNON   (Spain)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

^h UNIVERSITY OF MILAN   (Italy)

Author keywords

Consensus document; Retinal vein occlusion

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BEVACIZUMAB; DEXAMETHASONE; FIBRINOLYTIC AGENT; HEPARIN; PEGAPTANIB; RANIBIZUMAB; STREPTOKINASE; TRIAMCINOLONE ACETONIDE;

ANASTOMOSIS; ANTERIOR SEGMENT NEOVASCULARIZATION; ARTERIOVENOUS SHEATHOTOMY; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CANNULATION; CARDIOVASCULAR DISEASE; CENTRAL RETINA VEIN OCCLUSION; CHORIORETINAL VENOUS ANASTOMOSIS; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE COURSE; EYE SURGERY; FOLLOW UP; HEMODILUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; LASER COAGULATION; MACULA PERFUSION; NEOVASCULAR GLAUCOMA; NEOVASCULARIZATION (PATHOLOGY); OPEN ANGLE GLAUCOMA; PATHOPHYSIOLOGY; PERIPHERAL NONPERFUSION; PRACTICE GUIDELINE; RADIAL OPTIC NEUROTOMY; RECURRENT DISEASE; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; RISK FACTOR; THROMBOPHILIA; TREATMENT PLANNING; VISUAL ACUITY; VITRECTOMY;

FLUORESCEIN ANGIOGRAPHY; HUMANS; RETINAL VEIN OCCLUSION; RISK FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 79956068310     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000327391     Document Type: Article

References (152)

1. Hayreh SS: Occlusion of the central retinal vessels. Br J Ophthalmol 1965;49:626-645.
2. Hayreh SS, Rojas P, Podhajsky P, Montague P, Woolson RF: Ocular neovascularization with retinal vascular occlusion. 3. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 1983;90:488-506. (Pubitemid 13059778)
3. Hayreh SS, Klugman MR, Beri M, Kimura AE, Podhajsky P: Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase. Graefes Arch Clin Exp Ophthalmol 1990;228:201-217. (Pubitemid 20150302)
4. Hayreh SS: Retinal vein occlusion. Indian J Ophthalmol 1994;42:109-132.
5. Coscas G, Dhermy P: Occlusions veineuses rétiniennes. Paris, Masson, 1978, pp 283-346.
6. Coscas G, Gaudric A: Natural course of nonaphakic cystoid macular edema. Surv Ophthalmol 1984;28(suppl):471-484. (Pubitemid 14076506)
7. Central Vein Occlusion Study Group: Baseline and early natural history report: the Central Vein Occlusion Study. Arch Ophthalmol 1993;111:1087-1095.
8. Central Vein Occlusion Study Group: A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion: the Central Vein Occlusion Study Group N Report. Ophthalmology 1995;102:1434-1444.
9. Frangieh GT, Green WR, Barraquer-Somers E, Finkelstein D: Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol 1982;100:1132-1140. (Pubitemid 12078142)
10. Duker JS, Brown GC: Anterior location of the crossing artery in branch retinal vein obstruction. Arch Ophthalmol 1989;107:998-1000. (Pubitemid 19183656)
11. Zhao J, Sastry SM, Sperduto RD, Chew EY, Remaley NA: Arteriovenous crossing patterns in branch retinal vein occlusion. Ophthalmology 1993;100:423-428. (Pubitemid 23088544)
12. Christoffersen NL, Larsen M: Pathophysiology and hemodynamics of branch retinal vein occlusion. Ophthalmology 1999;106:2054-2062. (Pubitemid 30194224)
13. Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, Kowalski JW, Nguyen H, Wong TY, International Eye Disease Consortium: The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2010;117:313-319.
14. Green WR, Chan CC, Hutchins GM, Terry JM: Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 1981;79:371-422.
15. Green WR: Retina; in Spencer WH (ed): Ophthalmic Pathology. An Atlas and Textbook, ed 3. Philadelphia, WB Saunders, 1985, p 589.
16. Jonas J, Paques M, Monés J, Glacet-Bernard A, Coscas G: Retinal vein occlusions. Dev Ophthalmol 2010;47:111-135.
17. Haymore JG, Mejico LJ: Retinal vascular occlusion syndromes. Int Ophthalmol Clin 2009;49:63-79.
18. Hayreh SS, Zimmerman M, Podhajsky P: Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994;117:429-441. (Pubitemid 24115701)
19. Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ: Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A metaanalysis of thrombophilic factors. Thromb Haemost 2005;93:1021-1026. (Pubitemid 40823503)
20. Williamson TH: Central retinal vein occlusion: what's the story? Br J Ophthalmol 1977;81:698-704.
21. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P: Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001;131:61-77. (Pubitemid 32037010)
22. Recchia FM, Brown GC: Systemic disorders associated with retinal vascular occlusion. Curr Opin Ophthalmol 2000;11:462-467.
23. Yau JW, Lee P, Wong TY, Best J, Jenkins A: Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Intern Med J 2008;38:904-910.
24. Dodson PM, Kritzinger EE: Underlying medical conditions in young patients and ethnic differences in retinal vein occlusion. Trans Ophthalmol Soc UK 1985;104:114-119. (Pubitemid 15137419)
25. Dodson PM, Kritzinger EE: Medical cardiovascular treatment trials: relevant to medical ophthalmology in 1997? Eye (Lond) 1997;11(pt 1):3-11. (Pubitemid 27165800)
26. Eye Disease Case-Control Study Group: Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996;114:545-554.
27. Di Capua M, Coppola A, Albisinni R, Tufano A, Guida A, di Minno MN, Cirillo F, Loffredo M, Cerbone AM: Cardiovascular risk factors and outcome in patients with retinal vein occlusion. J Thromb Thrombolysis 2010;30:16-22.
28. Dodson PM, Galton DJ, Hamilton AM, Blach RK: Retinal vein occlusion and the prevalence of lipoprotein abnormalities. Br J Ophthalmol 1982;66:161-164. (Pubitemid 12176893)
29. Eye Disease Case-Control Study Group: Risk factors for branch retinal vein occlusion. Am J Ophthalmol 1993;116:286-296.
30. Dodson PM, Kritzinger EE, Clough CG: Diabetes mellitus and retinal vein occlusion in patients of Asian, West Indian and White European origin. Eye (Lond) 1992;6:66-68. (Pubitemid 23055149)
31. Lim LL, Cheung N, Wang JJ, Islam FM, Mitchell P, Saw SM, Aung T, Wong TY: Prevalence and risk factors of retinal vein occlusion in an Asian population. Br J Ophthalmol 2008;92:1316-1319.
32. O'Mahoney PR, Wong DT, Ray JG: Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol 2008;126:692-699. (Pubitemid 351679566)
33. Prisco D, Marcucci R, Bertini L, Gori AM: Cardiovascular and thrombophilic risk factors for central retinal vein occlusion. Eur J Intern Med 2002;13:163-169. (Pubitemid 34518506)
34. Salaun N, Delyfer MN, Rougier MB, Korobelnik JF: Evaluation du bilan étiologique des occlusions veineuses rétiniennes du sujet âgé de moins de 60 ans. J Fr Ophthalmol 2007;20:918-923.
35. Shrestha RK, Shrestha JK, Koirala S, Shah DN: Association of systemic diseases with retinal vein occlusive disease. JNMA J Nepal Med Assoc 2006;45:244-248.
36. Sodi A, Giambene B, Marcucci R, Sofi F, Fedi S, Abbate R, Prisco D, Menchini U: Atherosclerotic and thrombophilic risk factors in patients with ischemic central retinal vein occlusion. Retina 2010, E-pub ahead of print.
37. Wang S, Xu L, Jonas JB, Wong TY, Cui T, Li Y, Wang YX, You QS, Yang H, Sun C: Major eye diseases and risk factors associated with systemic hypertension in an adult Chinese population: the Beijing Eye Study. Ophthalmology 2009;116:2373-2380.
38. Yasuda M, Kiyohara Y, Arakawa S, Hata Y, Yonemoto K, Doi Y, Iida M, Ishibashi T: Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: the Hisayama study. Invest Ophthalmol Vis Sci 2010;51:3205-3209.
39. Elman MJ, Bhatt AK, Quinlan PM, Enger C: The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion. Ophthalmology 1990;97:1543-1548. (Pubitemid 20383293)
40. Mitchell P, Smith W, Chang A: Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study. Arch Ophthalmol 1996;114:1243-1247. (Pubitemid 26338856)
41. Rath EZ, Frank RN, Shin DH, Kim C: Risk factors for retinal vein occlusions: a case-control study. Ophthalmology 1992;99:509-514.
42. Hirota A, Mishima HK, Kiuchi Y: Incidence of retinal vein occlusion at the Glaucoma Clinic of Hiroshima University. Ophthalmologica 1997;211:288-291. (Pubitemid 27356199)
43. Sofi F, Marcucci R, Fedi S, Giambene B, Sodi A, Menchini U, Gensini GF, Abbate R, Prisco D: High lipoprotein (a) levels are associated with an increased risk of retinal vein occlusion. Atherosclerosis 2010;210:278-281.
44. Stojakovic T, Scharnagl H, März W, Winkelmann BR, Boehm BO, Schmut O: Low density lipoprotein triglycerides and lipoprotein (a) are risk factors for retinal vascular occlusion. Clin Chim Acta 2007;382:77-81. (Pubitemid 46782737)
45. Turello M, Pasca S, Daminato R, dello Russo P, Giacomello R, Venturelli U, Barillari G: Retinal vein occlusion: evaluation of 'classic' and 'emerging' risk factors and treatment. J Thromb Thrombolysis 2010;29:459-464.
46. Rehak M, Krcova V, Slavik L, Fric E, Langova K, Ulehlova J, Rehak J: The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors. Can J Ophthalmol 2010;45:171-175.
47. Kuhli-Hattenbach C, Scharrer I, Lüchtenberg M, Hattenbach LO: Coagulation disorders and the risk of retinal vein occlusion. Thromb Haemost 2010;103:299-305.
48. Lahey JM, Tunç M, Kearney J, Modlinski B, Koo H, Johnson RN, Tanaka S: Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. Ophthalmology 2002;109:126-131. (Pubitemid 34027435)
49. Larsson J, Hillarp A, Ólafsdóttir E, Bauer B: Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion. Acta Ophthalmol Scand 1999;77:634-637. (Pubitemid 30006802)
50. Fegan CD: Central retinal vein occlusion and thrombophilia. Eye (Lond) 2002;16:98-106. (Pubitemid 34257333)
51. Bertram B, Remky A, Arend O, Wolf S, Reim M: Protein C, protein S, and antithrombin III in acute ocular occlusive diseases. Ger J Ophthalmol 1995;4:332-335.
52. Kirwan JF, Tsaloumas MD, Vinall H, Prior P, Kritzinger EE, Dodson PM: Sex hormone preparations and retinal vein occlusion. Eye (Lond) 1997;11:53-56. (Pubitemid 27165809)
53. Ciardella AP, Yannuzzi LA, Freund KB, Di Michele D, Nejat M, de Rosa JT, Daly JR, Sisco L: Factor V Leiden, activated protein C resistance, and retinal vein occlusion. Retina 1998;18:308-315. (Pubitemid 30387100)
54. Cruciani F, Moramarco A, Curto T, Labate A, Recupero V, Conti L, Gandolfo GM, Balacco Gabrieli C: MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risk factors for youth retinal vein occlusion. Clin Ter 2003;154:299-303. (Pubitemid 44897494)
55. Glacet-Bernard A, Les Jardins GL, Lasry S, Coscas G, Soubrane G, Souied E, Housset B: Obstructive sleep apnea among patients with retinal vein occlusion. Arch Ophthalmol 2010;128:1533-1538.
56. Central Retinal Vein Occlusion Study Group: Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997;115:486-491.
57. McIntosh RL, Rogers SL, Lim L, Cheung N, Wang JJ, Mitchell P, Kowalski JW, Nguyen HP, Wong TY: Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2010;117:1094-1123e15.
58. Scott IU, Van Veldhuisen PC, Oden NL, Ip MS, Blodi BA, Jumper JM, Figueroa M, SCORE Study Investigator Group: SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology 2009;116:504-512.
59. Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM: OZURDEX GENEVA Study Group: randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117:1134-1146.
60. Giuffre G, Randazzo-Papa G, Palumbo C: Central retinal vein occlusion in young people. Doc Ophthalmol 1992;80:127-132.
61. Hansen LL, Wiek J, Schade M, Müller-Stolzenburg N, Wiederholt M: Effect and compatibility of isovolaemic haemodilution in the treatment of ischaemic and nonischaemic central retinal vein occlusion. Ophthalmologica 1989;199:90-99. (Pubitemid 19226848)
62. Ramezani A, Entezari M, Moradian S, Tabatabaei H, Kadkhodaei S: Intravitreal triamcinolone for acute central retinal vein occlusion: a randomized clinical trial. Graefes Arch Clin Exp Ophthlamol 2006;244:1601-1606. (Pubitemid 44830818)
63. Tewari HK, Lemtor MT, Azad RV, Verma L: Argon laser photocoagulation in acute central retinal vein occlusion. Afro-Asian J Ophthalmol 1995;13:88-91.
64. Cugati S, Wang JJ, Rochtchina E, Mitchell P: Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol 2006;124:726-732.
65. Fong A C O, Shatz H: Central retinal vein occlusion in young adults. Surv Ophthalmol 1993;37:393-417. (Pubitemid 23144010)
66. Orth DH, Patz A: Retinal branch vein occlusion. Surv Ophthalmol 1978;22:357-376. (Pubitemid 8384633)
67. Walters RF, Spalton DJ: Central retinal vein occlusion in people aged 40 years or less: a review of 17 patients. Br J Ophthalmol 1990;74:30-35. (Pubitemid 20026677)
68. Chen HC, Wiek J, Gupta A, Luckie A, Kohner EM: Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion. Br J Ophthalmol 1998;82:162-167. (Pubitemid 28176992)
69. Rogers SL, McIntosh RL, Lim L, Mitchell P, Cheung N, Kowalski JW, Nguyen HP, Wang JJ, Wong TY: Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2010;117:1094-1101e5.
70. Branch Vein Occlusion Study Group: Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984;98:271-282.
71. Branch Vein Occlusion Study Group: Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion: a randomized clinical trial. Arch Ophthalmol 1986;104:34-41.
72. Shroff D, Mehta DK, Arora R, Narula R, Chauhan D: Natural history of macular status in recent-onset branch retinal vein occlusion: an optical coherence tomography study. Int Ophthalmol 2008;28:261-268. (Pubitemid 352044574)
73. Clemett RS, Kohner EM, Hamilton AM: The visual prognosis in retinal branch vein occlusion. Trans Ophthalmol Soc UK 1973;93:523-535.
74. Michels RG, Gass JD: The natural course of retinal branch vein obstruction. Trans Am Acad Ophthalmol Otolaryngol 1974;78:166-177.
75. Shilling JS, Kohner EM: New vessel formation in retinal branch vein occlusion. Br J Ophthalmol 1976;60:810-815. (Pubitemid 8020059)
76. Shilling JS, Jones CA: Retinal branch vein occlusion: a study of argon laser photocoagulation in the treatment of macular oedema. Br J Ophthalmol 1984;68:196-198. (Pubitemid 15134727)
77. Murakami T, Takagi H, Ohashi H, Kita M, Nishiwaki H, Miyamoto K, Watanabe D, Sakamoto A, Yamaike N, Yoshimura N: Role of posterior vitreous detachment induced by intravitreal tissue plasminogen activator in macular edema with central retinal vein occlusion. Retina 2007;27:1031-1037. (Pubitemid 350304003)
78. Royal College of Ophthalmologists: Interim guidelines for management of retinal vein occlusion: December 2010. 2010. http://www.rcophth.ac.uk.
79. Hansen LL, Wiek J, Wiederholt M: A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. Br J Ophthalmol 1989;73:895-899. (Pubitemid 20004003)
80. Wolf S, Arend O, Bertram B, Remky A, Schulte K, Wald KJ, Reim M: Hemodilution therapy in central retinal vein occlusion: one-year results of a prospective randomized study. Graefes Arch Clin Exp Ophthalmol 1994;232:33-39. (Pubitemid 24060668)
81. Hattenbach LO, Wellermann G, Steinkamp GW, Scharrer I, Koch FH, Ohrloff C: Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion. Ophthalmologica 1999;213:360-366. (Pubitemid 29524922)
82. Glacet-Bernard A, Zourdani A, Milhoub M, Maraqua N, Coscas G, Soubrane G: Effect of isovolemic hemodilution in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2001;239:909-914. (Pubitemid 34026516)
83. Glacet-Bernard A, Atassi M, Fardeau C, Romanet JP, Tonini M, Conrath J, Denis P, Mauget-Faÿsse M, Coscas G, Soubrane G, Souied E: Hemodilution therapy using automated erythrocytapheresis in central retinal vein occlusion: results of a multicenter randomized controlled study. Graefes Arch Clin Exp Ophthalmol 2010, E-pub ahead of print.
84. Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG, Murahashi WY, CRUISE Investigators: Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010;117:1124-1133e1.
85. Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG, BRAVO Investigators: Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010;117:1102-1112.
86. Hayreh SS: Management of central retinal vein occlusion. Ophthalmologica 2003;217:167-188. (Pubitemid 36359529)
87. Coscas G, Coscas F, Vismara S, Zourdani A, Li Calzi C: Bright hyper-reflective spots and dense zones; in Coscas G (ed): Optical Coherence Tomography in Age-Related Macular Degeneration. Heidelberg, Springer, 2009, chapt 7, pp 159-167.
88. Central Vein Occlusion Study Group: Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology 1995;102:1425-1433.
89. Scott IU, Ip MS, Van Veldhuisen PC, Oden NL, Blodi BA, Fisher M, Chan CK, Gonzalez VH, Singerman LJ, Tolentino M, SCORE Study Research Group: A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care versus Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol 2009;127:1115-1128, erratum 1655.
90. Ip MS, Scott IU, Van Veldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH, SCORE Study Research Group: A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care versus Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009;127:1101-1114.
91. Ferrara DC, Koizumi H, Spaide RF: Early bevacizumab treatment of central retinal vein occlusion. Am J Ophthalmol 2007;144:864-871. (Pubitemid 350122344)
92. Figueroa MS, Contreras I, Noval S, Arruabarrena C: Results of bevacizumab as the primary treatment for retinal vein occlusion. Br J Ophthalmol 2010;94:1052-1056.
93. Wroblewski JJ, Wells JA 3rd, Adamis AP, Buggage RR, Cunningham ET Jr, Goldbaum M, Guyer DR, Katz B, Altaweel MM: Pegaptanib in Central Retinal Vein Occlusion Study Group: pegaptanib sodium for macular edema secondary to central retinal vein occlusion. Arch Ophthalmol 2009;127:374-380.
94. Sadda S, Danis R, Jico J, Li X-Y: Vascular changes in patients treated with dexamethasone intravitreal implant for macular edema due to BRVO or CRVO over 12 months. Poster presented at the Joint Meeting of the American Academy of Ophthalmology and the Middle East Africa Council of Ophthalmology (MEACO), Chicago, 2010.
95. Browning DJ, Scott AQ, Peterson CB, Warnock J, Zhang Z: The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion. Ophthalmology 1998;105:776-784. (Pubitemid 28225480)
96. Beutel J, Peters S, Lüke M, Aisenbrey S, Szurman P, Spitzer MS, Yoeruek E, Bevacizumab Study Group, Grisanti S: Bevacizumab as adjuvant for neovascular glaucoma. Acta Ophthalmol 2010;88:103-109.
97. Moraczewski AL, Lee RK, Palmberg PF, Rosenfeld PJ, Feuer WJ: Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. Br J Ophthalmol 2009;93:589-593.
98. Parodi MB, Friberg TR, Pedio M, Fiotti N, di Stefano G, Ravalico G: Panretinal photocoagulation and photodynamic therapy for anterior segment neovascularization secondary to ischemic central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2007;38:94-99. (Pubitemid 46668392)
99. Battaglia Parodi M, Saviano S, Ravalico G: Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 1999;237:1024-1027. (Pubitemid 30021293)
100. Rosenfeld PJ, Moshfeghi AA, Puliafito CA: Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:331-335. (Pubitemid 41073112)
101. Iturralde D, Spaide RF, Meyrele CB, Klancnik JM, Yannuzzi LA, Fisher YL, Sorenson J, Slakter JS, Freund KB, Cooney M, Fine HF: Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 2006;26:279-284. (Pubitemid 44318180)
102. Jaissle GB, Ziemssen F, Petermeier K, Szurman P, Ladewig M, Gelisken F, Voelker M, Holz FG, Bartz-Schmidt KU: Bevacizumab zur Therapie des sekundären Makulaödems nach venösen Gefässverschlüssen. Ophthalmologe 2006;103:471-475. (Pubitemid 43892185)
103. Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU: Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: IBeVO study. Retina 2007;27:141-149.
104. Matsumoto Y, Freund KB, Peiretti E, Cooney MJ, Ferrara DC, Yannuzzi LA: Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina 2007;27:426-431. (Pubitemid 46624281)
105. Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL: Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007;27:419-425. (Pubitemid 46624280)
106. Spandau UH, Ihloff AK, Jonas JB: Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion. Acta Ophthalmol 2006;84:555-556. (Pubitemid 44109048)
107. Rosenfeld PJ, Fung AE, Puliafito CA: Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2005;36:336-339. (Pubitemid 41073113)
108. Koizumi H, Ferrara DC, Bruè C, Spaide RF: Central retinal vein occlusion case-control study. Am J Ophthalmol 2007;144:858-863.
109. McIntosh RL, Mohamed Q, Saw SM, Wong TY: Interventions for branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2007;114:835-854.
110. Arevalo JF, Garcia RA, Wu L, Rodriguez FJ, Dalma-Weiszhausz J, Quiroz-Mercado H, Morales-Canton V, Roca JA, Berrocal MH, Graue-Wiechers F, Robledo V, Pan-American Collaborative Retina Study Group: Radial optic neurotomy for central retinal vein occlusion: results of the Pan-American Collaborative Retina Study Group (PACORES). Retina 2008;28:1044-1052.
111. Spaide RF, Klancnik JM Jr, Gross NE: Retinal choroidal collateral circulation after radial optic neurotomy correlated with the lessening of macular oedema. Retina 2004;24:356-359. (Pubitemid 38780462)
112. Garcia-Arumi J, Martinez-Castillo V, Boixadera A, Blasco H, Corcostegui B: Management of macular edema in branch retinal vein occlusion with sheathotomy and recombinant tissue plasminogen activator. Retina 2004;24:530-540. (Pubitemid 39079877)
113. Opremcak EM, Bruce RA, Lomeo MD, Ridenour CD, Letson AD, Rehmar AJ: Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina 2001;21:408-415. (Pubitemid 32971349)
114. Hasselbach HC, Ruefer F, Feltgen N, Schneider U, Bopp S, Hansen LL, Hoerauf H, Bartz-Schmidt U, Roider J: Treatment of central retinal vein occlusion by radial optic neurotomy in 107 cases. Graefes Arch Clin Exp Ophthalmol 2007;245:1145-1156. (Pubitemid 47034338)
115. Williamson TH, Poon W, Whitefield L, Strothidis N, Jaycock P: A pilot study of pars plana vitrectomy, intraocular gas and radial neurotomy in ischaemic central retinal vein occlusion. Br J Ophthalmol 2003;87:1126-1129. (Pubitemid 37064889)
116. Nomoto H, Shiraga F, Yamaji H, Kageyama M, Takenaka H, Baba T, Tsuchida Y: Evaluation of radial optic neurotomy for central retinal vein occlusion by indocyanine green videoangiography and image analysis. Am J Ophthalmol 2004;138:612-619. (Pubitemid 39420490)
117. Opremcak EM, Rehmar AJ, Ridenour CD, Kurz DE: Radial optic neurotomy for central retinal vein occlusion: 117 consecutive cases. Retina 2006;26:297-305. (Pubitemid 44318183)
118. Opremcak EM, Rehmar AJ, Ridenour CD, Kurz DE, Borkowski LM: Radial optic neurotomy with adjunctive intraocular triamcinolone for central retinal vein occlusion: 63 consecutive cases. Retina 2006;26:306-313. (Pubitemid 44318184)
119. Fortunato P, Pollazzi L, Baroni M, Evangelisti A, La Torre A: Venous retinal flow reperfusion mechanisms following radial optic neurotomy with adjunctive intraocular triamcinolone in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2010;248:167-173.
120. Martinez-Jardon CS, Meza-de Regil A, Dalma-Weiszhausz J, Leizaola-Fernandez C, Morales-Canton V, Guerrero-Naranjo JL, Quiroz-Mercado H: Radial optic neurotomy for ischaemic central vein occlusion. Br J Ophthalmol 2005;89:558-561. (Pubitemid 40569710)
121. Patelli F, Radice P, Zumbo G, Fasolino G, Marchi S: Optical coherence tomography evaluation of macular oedema after radial optic neurotomy in patients affected by central retinal vein occlusion. Semin Ophthalmol 2004;19:21-24. (Pubitemid 39658405)
122. Tsujikawa A, Hangai M, Kikuchi M, Ishida K, Kurimoto Y: Visual field defect after radial optic neurotomy for central retinal vein occlusion. Jpn J Ophthalmol 2006;50:158-160.
123. McAllister IL, Douglas JP, Constable IJ, Yu DY: Laser-induced chorioretinal venous anastomosis for non-ischaemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol 1998;126:219-229. (Pubitemid 28397095)
124. Peyman GA, Kishore K, Conway MD: Surgical chorioretinal venous anastomosis for ischemic central retinal vein occlusion. Ophthalmic Surg Lasers 1999;30:605-614. (Pubitemid 29450733)
125. Sharma A, D'Amico D: Medical and surgical management of central retinal vein occlusion. Int Ophthalmol Clin 2004;44:1-16. (Pubitemid 38174193)
126. Quiroz-Mercado H, Sanchez-Buenfil E, Guerrero-Naranjo JL, Ochoa-Contreras D, Ruiz-Cruz M, Marcellino G, Damico DJ: Successful erbium:YAG laser-induced chorioretinal venous anastomosis for the management of ischaemic central retinal vein occlusion: a report of two cases. Graefes Arch Clin Exp Ophthalmol 2001;239:872-875. (Pubitemid 33114941)
127. Mirshahi A, Roohipoor R, Lashay A, Mohammadi SF, Mansouri MR: Surgical induction of chorioretinal venous anastomosis in ischaemic central retinal vein occlusion: a non-randomized controlled clinical trial. Br J Ophthalmol 2005;89:64-69. (Pubitemid 40040241)
128. Koizumi K, Nishiura M, Yamamoto T, Machida T, Nakamura T, Ouchi M, Kinoshita S: Intentional complete interruption of a retinal vein after vitrectomy might improve the rate of successful chorioretinal venous anastomosis formation in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002;240:787-794. (Pubitemid 36075632)
129. Furino C, Ferrari TM, Boscia F, Cardascia N, Sborgia L, Reibald M, Ferreri P, Sborgia C: Combined radial optic neurotomy, internal limiting membrane peeling, and intravitreal triamcinolone acetonide for central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2005;36:422-425. (Pubitemid 41413200)
130. Liang XL, Chen HY, Huang YS, Eong K G A, Yu SS, Liu X, Yan H: Pars plana vitrectomy and internal limiting membrane peeling for macular oedema secondary to retinal vein occlusion: a pilot study. Ann Acad Med Singapore 2007;36:293-297. (Pubitemid 47309193)
131. Mandelcorn MS, Nrusimhadevara RK: Internal limiting membrane peeling for decompression of macular oedema in retinal vein occlusion: a report of 14 cases. Retina 2004;24:348-355. (Pubitemid 38780461)
132. Park DH, Kim IT: Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion. Retina 2010;30:117-124.
133. Nkeme J, Glacet-Bernard A, Gnikpingo K, Zourdani A, Mimoun G, Mahiddine H, Gkoritsa A, Tchamo A, Coscas G, Soubrane G: Surgical treatment of persistent macular edema in retinal vein occlusion. J Fr Ophthalmol 2006;29:808-814. (Pubitemid 44427493)
134. Kumagai K, Furukawa M, Ogino N, Uemura A, Larson E: Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina 2007;27:49-54. (Pubitemid 46095830)
135. Kumagai K, Furukawa M, Ogino N, Larson E, Uemura A: Long-term visual outcomes after vitrectomy for macular edema with foveal hemorrhage in branch retinal vein occlusion. Retina 2007;27:584-588. (Pubitemid 46905149)
136. Berker N, Batman C: Surgical treatment of central retinal vein occlusion. Acta Ophthalmol 2008;86:245-252. (Pubitemid 351785095)
137. De Croos FC, Shuler RK Jr, Stinnett S, Fekrat S: Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion. Am J Ophthalmol 2009;147:627-633e1.
138. Lu N, Wang NL, Wang GL, Li XW, Wang Y: Vitreous surgery with direct central retinal artery massage for central retinal artery occlusion. Eye (Lond) 2009;23:867-872.
139. Uemura A, Yamamoto S, Sato E, Sugawara T, Mitamura Y, Mizunoya S: Vitrectomy alone versus vitrectomy with simultaneous intravitreal injection of triamcinolone for macular edema associated with branch retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2009;40:6-12.
140. Arai M, Yamamoto S, Mitamura Y, Sato E, Sugawara T, Mizunoya S: Efficacy of vitrectomy and internal limiting membrane removal for macular edema associated with branch retinal vein occlusion. Ophthalmologica 2008;223:172-176.
141. Oh IK, Kim S, Oh J, Huh K: Long-term visual outcome of arteriovenous adventitial sheathotomy on branch retinal vein occlusion induced macular edema. Korean J Ophthalmol 2008;22:1-5.
142. Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S, Hori S: Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular oedema. Ophthalmology 2003;110:1690-1696. (Pubitemid 37025424)
143. Funatsu H, Yamashita H, Ikeda T, Mimura T, Shimizu E, Hori S: Relation of diabetic macular oedema to cytokines and posterior vitreous detachment. Am J Ophthalmol 2003;135:321-327. (Pubitemid 36279518)
144. Saika S, Tanaka T, Miyamoto T, Ohnishi Y: Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular oedema associated with branch retinal vein occlusion: retinal tomography and visual outcome. Graefes Arch Clin Exp Ophthalmol 2001;239:729-732. (Pubitemid 33061876)
145. Noma H, Funatsu H, Sakata K, Mimura T, Hori S: Macular microcirculation before and after vitrectomy for macular edema with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2010;248:443-445.
146. Radetzky S, Walter P, Fauser S, Koizumi K, Kirchhof B, Joussen AM: Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine greenassisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 2004;242:273-278. (Pubitemid 38647598)
147. Weiss JN, Bynoe LA: Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 2001;108:2249-2257. (Pubitemid 33096938)
148. Feltgen N, Junker B, Agostini H, Hansen LL: Retinal endovascular lysis in ischaemic central retinal vein occlusion: one-year results of a pilot study. Ophthalmology 2007;114:716-723.
149. Osterloh MD, Charles S: Surgical decompression of branch retinal vein
150. Avci R, Inan UU, Kaderli B: Evaluation of arteriovenous crossing sheathotomy for decompression of branch retinal vein occlusion. Eye (Lond) 2008;22:120-127.
151. Chung EJ, Lee H, Koh HJ: Arteriovenous crossing sheathotomy versus intravitreal triamcinolone acetonide injection for treatment of macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2008;246:967-974.
152. NICE Interventional Procedure Guidance IPG334: Arteriovenous crossing sheathotomy for branch retinal vein occlusion. 2010. http://guidance.nice.org. uk/IPG334 (accessed September 22, 2010).